Brief: Starpharma Holdings Says CEO To Retire In 2024
June 9 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* STARPHARMA CEO TO RETIRE IN 2024
* FOLLOWING SIGNIFICANT TENURE AS COMPANY'S CHIEF EXECUTIVE
OFFICER JACKIE FAIRLEY HAS ADVISED SHE INTENDS TO RETIRE DURING
2024
* JACKIE FAIRLEY WILL CONTINUE IN ROLE OF CEO UNTIL A
SUCCESSOR IS
READY TO COMMENCE
Source text for Eikon: ID:nASX96NTSQ
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising